J7613 HCPCS code: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg

J7613 is the HCPCS Level II code for albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg. In 2024 Medicare paid an average of $0.04 per service for J7613 across 148,925 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 1395 per day on DME suppliers. Medicare volume rose 33% from 2022 to 2024 (112,137 to 148,925 services). In 2024, 32,767 suppliers billed Medicare for J7613 (purchases), serving 180,722 beneficiaries; California, Texas, New York accounted for 20% of services.

Code details

Who bills J7613 (2024)

Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.

Medicare utilization for J7613, 2022–2024

States with the most J7613 services (2024)

NCCI unit limits (MUE)

Medicare policy articles for this code

• A52466: Nebulizers - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance

Covered diagnoses (215 ICD-10-CM codes)

The diagnoses most often listed as covered in the policy articles above:

Showing 10 of 215. The full list, non-covered diagnoses and CSV export are in Caduvo.

What changed for J7613

• 2005-01-01: J7613 added to HCPCS Level II
• Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01

Frequently asked questions

What is HCPCS code J7613?

J7613 is the HCPCS Level II code for albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg. Short descriptor: "Albuterol non-comp unit".

How much does Medicare pay for J7613?

In 2024, the average Medicare payment was $0.04 per service (average allowed $0.05).

Does Medicare cover J7613?

Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.

Which diagnoses support coverage for J7613?

Medicare policy articles that cite J7613 list 215 covered ICD-10-CM diagnosis codes across 1 article. The most cited include A15.0 (Tuberculosis of lung), A22.1 (Pulmonary anthrax), A37.01 (Whooping cough due to Bordetella pertussis with pneumonia). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.

How many units of J7613 can be billed per day?

1395 on DME suppliers; 10 on practitioner claims (NCCI medically unlikely edits).

Related J76 codes

• J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
• J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
• J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
• J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
• J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
• J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
• J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
• J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
• J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
• J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
• J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
• J7615 — Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

• Run a reimbursement report for a device billed under J7613
• Watch J7613 for fee, coverage and descriptor changes
• Build a full Medicare revenue model for J7613

Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.

All J codes · HCPCS lookup